27
Participants
Start Date
December 15, 2017
Primary Completion Date
September 14, 2021
Study Completion Date
January 10, 2022
Ascorbic Acid
combination therapy
Paclitaxel protein-bound
combination therapy
Cisplatin
combination therapy
Gemcitabine
combination therapy
HonorHealth Research Institute, Scottsdale
Lead Sponsor
Collaborators (3)
Stand Up To Cancer
OTHER
Cancer Research UK
OTHER
Lustgarten Foundation
OTHER
Translational Genomics Research Institute
OTHER
Princeton University
OTHER
Salk Institute for Biological Studies
OTHER
Cold Spring Harbor Laboratory
OTHER
Barts Cancer Institute
OTHER
University of Arizona
OTHER
Imaging Endpoints
UNKNOWN
HonorHealth Research Institute
OTHER